0.2%盐酸奥洛他定滴眼液每日1次与0.1%盐酸奥洛他定滴眼液每日2次治疗中国过敏性结膜炎受试者的对比研究
[Translation] A comparative study of 0.2% olopatadine hydrochloride eye drops once a day and 0.1% olopatadine hydrochloride eye drops twice a day in the treatment of Chinese subjects with allergic conjunctivitis
本研究的主要目的是证实0.2%奥洛他定QD在治疗过敏性结膜炎相关的眼痒方面不劣于0.1%奥洛他定BID
[Translation] The primary objective of this study was to demonstrate that olopatadine 0.2% QD was noninferior to olopatadine 0.1% BID for the treatment of allergic conjunctivitis-related eye itching
在中国人群中评估0.5%莫西沙星滴眼液和0.3%氧氟沙星滴眼液治疗细菌性结膜炎的安全性与疗效
[Translation] To evaluate the safety and efficacy of 0.5% moxifloxacin eye drops and 0.3% ofloxacin eye drops in the treatment of bacterial conjunctivitis in a Chinese population
研究主要目的是通过在治愈检验访视(TOC)期间的临床治愈率以及微生物成功治愈率来证实0.5%莫西沙星滴眼液在治疗细菌性结膜炎方面非劣效于0.3%氧氟沙星滴眼液。
[Translation] The primary objective of the study was to demonstrate non-inferiority of 0.5% moxifloxacin eye drops to 0.3% ofloxacin in the treatment of bacterial conjunctivitis by clinical cure rate and microbiological success rate during the Test of Cure Visit (TOC). eye drops.
100 Clinical Results associated with Alcon (China) Ophthalmic Product Co. Ltd.
0 Patents (Medical) associated with Alcon (China) Ophthalmic Product Co. Ltd.
100 Deals associated with Alcon (China) Ophthalmic Product Co. Ltd.
100 Translational Medicine associated with Alcon (China) Ophthalmic Product Co. Ltd.